• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of microrevMicrobiol Mol Biol Rev ArchivePermissionsJournals.ASM.orgMMBR ArticleJournal InfoAuthorsReviewers
Microbiol Rev. Jun 1996; 60(2): 301–315.
PMCID: PMC239445

Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.

Abstract

Artemisinin and its derivatives are endoperoxide-containing compounds which represent a promising new class of antimalarial drugs. In the presence of intraparasitic iron, these drugs are converted into free radicals and other electrophilic intermediates which then alkylate specific malaria target proteins. Combinations of available derivatives and other antimalarial agents show promise both as first-line agents and in the treatment of severe disease.

Full Text

The Full Text of this article is available as a PDF (356K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Acton N, Karle JM, Miller RE. Synthesis and antimalarial activity of some 9-substituted artemisinin derivatives. J Med Chem. 1993 Aug 20;36(17):2552–2557. [PubMed]
  • Alin MH, Bjorkman A. Concentration and time dependency of artemisinin efficacy against Plasmodium falciparum in vitro. Am J Trop Med Hyg. 1994 Jun;50(6):771–776. [PubMed]
  • Arnold K. Early treatment of malaria in the community using artemisinin--hope or hazard? Trans R Soc Trop Med Hyg. 1994 Jun;88 (Suppl 1):S47–S49. [PubMed]
  • Asawamahasakda W, Benakis A, Meshnick SR. The interaction of artemisinin with red cell membranes. J Lab Clin Med. 1994 May;123(5):757–762. [PubMed]
  • Asawamahasakda W, Ittarat I, Chang CC, McElroy P, Meshnick SR. Effects of antimalarials and protease inhibitors on plasmodial hemozoin production. Mol Biochem Parasitol. 1994 Oct;67(2):183–191. [PubMed]
  • Asawamahasakda W, Ittarat I, Pu YM, Ziffer H, Meshnick SR. Reaction of antimalarial endoperoxides with specific parasite proteins. Antimicrob Agents Chemother. 1994 Aug;38(8):1854–1858. [PMC free article] [PubMed]
  • Avery MA, Gao F, Chong WK, Mehrotra S, Milhous WK. Structure-activity relationships of the antimalarial agent artemisinin. 1. Synthesis and comparative molecular field analysis of C-9 analogs of artemisinin and 10-deoxoartemisinin. J Med Chem. 1993 Dec 24;36(26):4264–4275. [PubMed]
  • Basco LK, Le Bras J. In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg. 1993 Sep;49(3):301–307. [PubMed]
  • Brewer TG, Grate SJ, Peggins JO, Weina PJ, Petras JM, Levine BS, Heiffer MH, Schuster BG. Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg. 1994 Sep;51(3):251–259. [PubMed]
  • Brewer TG, Peggins JO, Grate SJ, Petras JM, Levine BS, Weina PJ, Swearengen J, Heiffer MH, Schuster BG. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg. 1994 Jun;88 (Suppl 1):S33–S36. [PubMed]
  • Brossi A, Venugopalan B, Dominguez Gerpe L, Yeh HJ, Flippen-Anderson JL, Buchs P, Luo XD, Milhous W, Peters W. Arteether, a new antimalarial drug: synthesis and antimalarial properties. J Med Chem. 1988 Mar;31(3):645–650. [PubMed]
  • Bunnag D, Kanda T, Karbwang J, Thimasarn K, Pungpak S, Harinasuta T. Artemether-mefloquine combination in multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):213–215. [PubMed]
  • Bunnag D, Karbwang J, Harinasuta T. Artemether in the treatment of multiple drug resistant falciparum malaria. Southeast Asian J Trop Med Public Health. 1992 Dec;23(4):762–767. [PubMed]
  • Bunnag D, Viravan C, Looareesuwan S, Karbwang J, Harinasuta T. Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria. Southeast Asian J Trop Med Public Health. 1991 Dec;22(4):539–543. [PubMed]
  • Bunnag D, Viravan C, Looareesuwan S, Karbwang J, Harinasuta T. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report. Southeast Asian J Trop Med Public Health. 1991 Sep;22(3):380–385. [PubMed]
  • Bunnag D, Viravan C, Looareesuwan S, Karbwang J, Harinasuta T. Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria. Southeast Asian J Trop Med Public Health. 1991 Dec;22(4):534–538. [PubMed]
  • Caillard V, Beauté-Lafitte A, Chabaud AG, Landau I. Plasmodium vinckei petteri: identification of the stages sensitive to arteether. Exp Parasitol. 1992 Dec;75(4):449–456. [PubMed]
  • Chang HR, Pechère JC. Arteether, a qinghaosu derivative, in toxoplasmosis. Trans R Soc Trop Med Hyg. 1988;82(6):867–867. [PubMed]
  • Chawira AN, Warhurst DC, Robinson BL, Peters W. The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice. Trans R Soc Trop Med Hyg. 1987;81(4):554–558. [PubMed]
  • Chen H, Maibach HI. Topical application of artesunate on guinea pig allergic contact dermatitis. Contact Dermatitis. 1994 May;30(5):280–282. [PubMed]
  • Chen YT, Ma L, Mei Q, Tang Y, Liao XG. An experimental trial of artemether in treatment of Pneumocystis carinii in immunosuppressed rats. Chin Med J (Engl) 1994 Sep;107(9):673–677. [PubMed]
  • Chi HT, Ramu K, Baker JK, Hufford CD, Lee IS, Zeng YL, McChesney JD. Identification of the in vivo metabolites of the antimalarial arteether by thermospray high-performance liquid chromatography/mass spectrometry. Biol Mass Spectrom. 1991 Oct;20(10):609–628. [PubMed]
  • Chou AC, Chevli R, Fitch CD. Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry. 1980 Apr 15;19(8):1543–1549. [PubMed]
  • Davidson DE., Jr Role of arteether in the treatment of malaria and plans for further development. Trans R Soc Trop Med Hyg. 1994 Jun;88 (Suppl 1):S51–S52. [PubMed]
  • Duc DD, de Vries PJ, Nguyen XK, Le Nguyen B, Kager PA, van Boxtel CJ. The pharmacokinetics of a single dose of artemisinin in healthy Vietnamese subjects. Am J Trop Med Hyg. 1994 Dec;51(6):785–790. [PubMed]
  • Dutta GP, Mohan A, Tripathi R. Study of the gametocytocidal/sporontocidal action of qinghaosu (artemisinin) by electron microscopy. J Parasitol. 1990 Dec;76(6):849–852. [PubMed]
  • Ekong R, Warhurst DC. Synergism between arteether and mefloquine or quinine in a multidrug-resistant strain of Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg. 1990 Nov-Dec;84(6):757–758. [PubMed]
  • Elford BC, Roberts MF, Phillipson JD, Wilson RJ. Potentiation of the antimalarial activity of qinghaosu by methoxylated flavones. Trans R Soc Trop Med Hyg. 1987;81(3):434–436. [PubMed]
  • Elhassan IM, Satti GH, Ali AE, Fadul I, Elkhalifa AA, Abedelrahim AM, Ming C, Theander TG. The efficacy of artemether in the treatment of Plasmodium falciparum malaria in Sudan. Trans R Soc Trop Med Hyg. 1993 Nov-Dec;87(6):685–686. [PubMed]
  • Ellis DS, Li ZL, Gu HM, Peters W, Robinson BL, Tovey G, Warhurst DC. The chemotherapy of rodent malaria, XXXIX. Ultrastructural changes following treatment with artemisinine of Plasmodium berghei infection in mice, with observations of the localization of [3H]-dihydroartemisinine in P. falciparum in vitro. Ann Trop Med Parasitol. 1985 Aug;79(4):367–374. [PubMed]
  • Fairfield AS, Abosch A, Ranz A, Eaton JW, Meshnick SR. Oxidant defense enzymes of Plasmodium falciparum. Mol Biochem Parasitol. 1988 Jul;30(1):77–82. [PubMed]
  • Fishwick J, McLean WG, Edwards G, Ward SA. The toxicity of artemisinin and related compounds on neuronal and glial cells in culture. Chem Biol Interact. 1995 Jun 14;96(3):263–271. [PubMed]
  • Fry M, Beesley JE. Mitochondria of mammalian Plasmodium spp. Parasitology. 1991 Feb;102(Pt 1):17–26. [PubMed]
  • Gabay T, Krugliak M, Shalmiev G, Ginsburg H. Inhibition by anti-malarial drugs of haemoglobin denaturation and iron release in acidified red blood cell lysates--a possible mechanism of their anti-malarial effect? Parasitology. 1994 May;108(Pt 4):371–381. [PubMed]
  • Geary TG, Divo AA, Jensen JB. Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture. Am J Trop Med Hyg. 1989 Mar;40(3):240–244. [PubMed]
  • Gu HM, Inselburg J. Premature release of Plasmodium falciparum from swollen erythrocytes induced by some antimalarials. J Parasitol. 1989 Feb;75(1):153–157. [PubMed]
  • Gu HM, Warhurst DC, Peters W. Uptake of [3H] dihydroartemisinine by erythrocytes infected with Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg. 1984;78(2):265–270. [PubMed]
  • Gu HM, Warhurst DC, Peters W. Hemolysis induced by artemisinin and its derivatives in vitro. Zhongguo Yao Li Xue Bao. 1986 May;7(3):269–272. [PubMed]
  • Hien TT, Arnold K, Vinh H, Cuong BM, Phu NH, Chau TT, Hoa NT, Chuong LV, Mai NT, Vinh NN, et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):582–583. [PubMed]
  • Hien TT, Phu NH, Mai NT, Chau TT, Trang TT, Loc PP, Cuong BM, Dung NT, Vinh H, Waller DJ, et al. An open randomized comparison of intravenous and intramuscular artesunate in severe falciparum malaria. Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):584–585. [PubMed]
  • Hien TT, Tam DT, Cuc NT, Arnold K. Comparative effectiveness of artemisinin suppositories and oral quinine in children with acute falciparum malaria. Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):210–211. [PubMed]
  • Hien TT, White NJ. Qinghaosu. Lancet. 1993 Mar 6;341(8845):603–608. [PubMed]
  • Hofheinz W, Bürgin H, Gocke E, Jaquet C, Masciadri R, Schmid G, Stohler H, Urwyler H. Ro 42-1611 (arteflene), a new effective antimalarial: chemical structure and biological activity. Trop Med Parasitol. 1994 Sep;45(3):261–265. [PubMed]
  • Holfels E, McAuley J, Mack D, Milhous WK, McLeod R. In vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii. Antimicrob Agents Chemother. 1994 Jun;38(6):1392–1396. [PMC free article] [PubMed]
  • Homewood CA, Jewsbury JM, Chance ML. The pigment formed during haemoglobin digestion by malarial and schistosomal parasites. Comp Biochem Physiol B. 1972 Nov 15;43(3):517–523. [PubMed]
  • Hong YL, Yang YZ, Meshnick SR. The interaction of artemisinin with malarial hemozoin. Mol Biochem Parasitol. 1994 Jan;63(1):121–128. [PubMed]
  • Ittarat I, Asawamahasakda W, Meshnick SR. The effects of antimalarials on the Plasmodium falciparum dihydroorotate dehydrogenase. Exp Parasitol. 1994 Aug;79(1):50–56. [PubMed]
  • Jaquet C, Stohler HR, Chollet J, Peters W. Antimalarial activity of the bicyclic peroxide Ro 42-1611 (arteflene) in experimental models. Trop Med Parasitol. 1994 Sep;45(3):266–271. [PubMed]
  • Jiang JB, Jacobs G, Liang DS, Aikawa M. Qinghaosu-induced changes in the morphology of Plasmodium inui. Am J Trop Med Hyg. 1985 May;34(3):424–428. [PubMed]
  • Jiang JB, Li GQ, Guo XB, Kong YC, Arnold K. Antimalarial activity of mefloquine and qinghaosu. Lancet. 1982 Aug 7;2(8293):285–288. [PubMed]
  • Jonkman A, Chibwe RA, Khoromana CO, Liabunya UL, Chaponda ME, Kandiero GE, Molyneux ME, Taylor TE. Cost-saving through microscopy-based versus presumptive diagnosis of malaria in adult outpatients in Malawi. Bull World Health Organ. 1995;73(2):223–227. [PMC free article] [PubMed]
  • Jung M, Li X, Bustos DA, elSohly HN, McChesney JD, Milhous WK. Synthesis and antimalarial activity of (+)-deoxoartemisinin. J Med Chem. 1990 May;33(5):1516–1518. [PubMed]
  • Kager PA, Schultz MJ, Zijlstra EE, van den Berg B, van Boxtel CJ. Arteether administration in humans: preliminary studies of pharmacokinetics, safety and tolerance. Trans R Soc Trop Med Hyg. 1994 Jun;88 (Suppl 1):S53–S54. [PubMed]
  • Kamchonwongpaisan S, Chandra-ngam G, Avery MA, Yuthavong Y. Resistance to artemisinin of malaria parasites (Plasmodium falciparum) infecting alpha-thalassemic erythrocytes in vitro. Competition in drug accumulation with uninfected erythrocytes. J Clin Invest. 1994 Feb;93(2):467–473. [PMC free article] [PubMed]
  • Kamchonwongpaisan S, Paitayatat S, Thebtaranonth Y, Wilairat P, Yuthavong Y. Mechanism-based development of new antimalarials: synthesis of derivatives of artemisinin attached to iron chelators. J Med Chem. 1995 Jun 23;38(13):2311–2316. [PubMed]
  • Karbwang J, Na Bangchang K, Thanavibul A, Back DJ, Bunnag D, Harinasuta T. Pharmacokinetics of mefloquine alone or in combination with artesunate. Bull World Health Organ. 1994;72(1):83–87. [PMC free article] [PubMed]
  • Karbwang J, Bangchang KN, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria. Lancet. 1992 Nov 21;340(8830):1245–1248. [PubMed]
  • Karbwang J, Na-Bangchang K, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria. Bull World Health Organ. 1994;72(2):233–238. [PMC free article] [PubMed]
  • Karbwang J, Na-Bangchang K, Thanavibul A, Ditta-in M, Harinasuta T. A comparative clinical trial of two different regimens of artemether plus mefloquine in multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg. 1995 May-Jun;89(3):296–298. [PubMed]
  • Karbwang J, Sukontason K, Rimchala W, Namsiripongpun W, Tin T, Auprayoon P, Tumsupapong S, Bunnag D, Harinasuta T. Preliminary report: a comparative clinical trial of artemether and quinine in severe falciparum malaria. Southeast Asian J Trop Med Public Health. 1992 Dec;23(4):768–772. [PubMed]
  • Kawai S, Kano S, Suzuki M. Morphologic effects of artemether on Plasmodium falciparum in Aotus trivirgatus. Am J Trop Med Hyg. 1993 Dec;49(6):812–818. [PubMed]
  • Ke OY, Krug EC, Marr JJ, Berens RL. Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives. Antimicrob Agents Chemother. 1990 Oct;34(10):1961–1965. [PMC free article] [PubMed]
  • Kepler JA, Philip A, Lee YW, Morey MC, Carroll FI. 1,2,4-Trioxanes as potential antimalarial agents. J Med Chem. 1988 Apr;31(4):713–716. [PubMed]
  • Kessler DA, Feiden KL. Faster evaluation of vital drugs. Sci Am. 1995 Mar;272(3):48–54. [PubMed]
  • Klayman DL. Qinghaosu (artemisinin): an antimalarial drug from China. Science. 1985 May 31;228(4703):1049–1055. [PubMed]
  • Klayman DL, Ager AL, Jr, Fleckenstein L, Lin AJ. Transdermal artelinic acid: an effective treatment for Plasmodium berghei-infected mice. Am J Trop Med Hyg. 1991 Nov;45(5):602–607. [PubMed]
  • Krungkrai SR, Yuthavong Y. The antimalarial action on Plasmodium falciparum of qinghaosu and artesunate in combination with agents which modulate oxidant stress. Trans R Soc Trop Med Hyg. 1987;81(5):710–714. [PubMed]
  • Kumar N, Zheng H. Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitol Res. 1990;76(3):214–218. [PubMed]
  • Lai H, Singh NP. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett. 1995 May 4;91(1):41–46. [PubMed]
  • Lee IS, Hufford CD. Metabolism of antimalarial sesquiterpene lactones. Pharmacol Ther. 1990;48(3):345–355. [PubMed]
  • Levander OA, Ager AL, Jr, Morris VC, May RG. Qinghaosu, dietary vitamin E, selenium, and cod-liver oil: effect on the susceptibility of mice to the malarial parasite Plasmodium yoelii. Am J Clin Nutr. 1989 Aug;50(2):346–352. [PubMed]
  • Li GQ, Arnold K, Guo XB, Jian HX, Fu LC. Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria. Lancet. 1984 Dec 15;2(8416):1360–1361. [PubMed]
  • Li GQ, Guo XB, Jian HX, Fu LC, Shen LC, Li RS, Dai BQ, Li ZL. Observation on the efficacy of qinghaosu suppository in 100 cases of falciparum malaria. J Tradit Chin Med. 1985 Sep;5(3):159–161. [PubMed]
  • Li GQ, Guo XB, Jin R, Wang ZC, Jian HX, Li ZY. Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives. J Tradit Chin Med. 1982 Jun;2(2):125–130. [PubMed]
  • Li WH, Shu HL, Xu GY, Zeng YL. [The binding of qinghaosu (artemisinine) and its derivatives to plasma protein]. Yao Xue Xue Bao. 1982 Oct;17(10):783–786. [PubMed]
  • Li X, Rieckmann K. A bioassay for derivatives of qinghaosu (artemisinin). Trop Med Parasitol. 1992 Sep;43(3):195–196. [PubMed]
  • Lin AJ, Klayman DL, Milhous WK. Antimalarial activity of new water-soluble dihydroartemisinin derivatives. J Med Chem. 1987 Nov;30(11):2147–2150. [PubMed]
  • Lin AJ, Lee M, Klayman DL. Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 2. Stereospecificity of the ether side chain. J Med Chem. 1989 Jun;32(6):1249–1252. [PubMed]
  • Lin AJ, Li LQ, Andersen SL, Klayman DL. Antimalarial activity of new dihydroartemisinin derivatives. 5. Sugar analogues. J Med Chem. 1992 May 1;35(9):1639–1642. [PubMed]
  • Lin AJ, Li LQ, Klayman DL, George CF, Flippen-Anderson JL. Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 3. Aromatic amine analogues. J Med Chem. 1990 Sep;33(9):2610–2614. [PubMed]
  • Lin AJ, Miller RE. Antimalarial activity of new dihydroartemisinin derivatives. 6. alpha-Alkylbenzylic ethers. J Med Chem. 1995 Mar 3;38(5):764–770. [PubMed]
  • Looareesuwan S, Viravan C, Vanijanonta S, Wilairatana P, Charoenlarp P, Canfield C, Kyle DE. Treatment of acute uncomplicated falciparum malaria with a short course of artesunate followed by mefloquine. Southeast Asian J Trop Med Public Health. 1993 Jun;24(2):230–234. [PubMed]
  • Looareesuwan S, Viravan C, Vanijanonta S, Wilairatana P, Charoenlarp P, Canfield CJ, Kyle DE. Randomized trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria. Am J Trop Med Hyg. 1994 Jun;50(6):784–789. [PubMed]
  • Looareesuwan S, Viravan C, Vanijanonta S, Wilairatana P, Suntharasamai P, Charoenlarp P, Arnold K, Kyle D, Canfield C, Webster K. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet. 1992 Apr 4;339(8797):821–824. [PubMed]
  • Luo XD, Shen CC. The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives. Med Res Rev. 1987 Jan-Mar;7(1):29–52. [PubMed]
  • Luxemburger C, ter Kuile FO, Nosten F, Dolan G, Bradol JH, Phaipun L, Chongsuphajaisiddhi T, White NJ. Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg. 1994 Mar-Apr;88(2):213–217. [PubMed]
  • Maeno Y, Toyoshima T, Fujioka H, Ito Y, Meshnick SR, Benakis A, Milhous WK, Aikawa M. Morphologic effects of artemisinin in Plasmodium falciparum. Am J Trop Med Hyg. 1993 Oct;49(4):485–491. [PubMed]
  • Mehra N, Bhasin VK. In vitro gametocytocidal activity of artemisinin and its derivatives on Plasmodium falciparum. Jpn J Med Sci Biol. 1993 Feb;46(1):37–43. [PubMed]
  • Melendez V, Peggins JO, Brewer TG, Theoharides AD. Determination of the antimalarial arteether and its deethylated metabolite dihydroartemisinin in plasma by high-performance liquid chromatography with reductive electrochemical detection. J Pharm Sci. 1991 Feb;80(2):132–138. [PubMed]
  • Merali S, Meshnick SR. Susceptibility of Pneumocystis carinii to artemisinin in vitro. Antimicrob Agents Chemother. 1991 Jun;35(6):1225–1227. [PMC free article] [PubMed]
  • Meshnick SR. Free radicals and antioxidants. Lancet. 1994 Nov 19;344(8934):1441–1442. [PubMed]
  • Meshnick SR. The mode of action of antimalarial endoperoxides. Trans R Soc Trop Med Hyg. 1994 Jun;88 (Suppl 1):S31–S32. [PubMed]
  • Meshnick SR, Thomas A, Ranz A, Xu CM, Pan HZ. Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. Mol Biochem Parasitol. 1991 Dec;49(2):181–189. [PubMed]
  • Meshnick SR, Tsang TW, Lin FB, Pan HZ, Chang CN, Kuypers F, Chiu D, Lubin B. Activated oxygen mediates the antimalarial activity of qinghaosu. Prog Clin Biol Res. 1989;313:95–104. [PubMed]
  • Meshnick SR, Yang YZ, Lima V, Kuypers F, Kamchonwongpaisan S, Yuthavong Y. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob Agents Chemother. 1993 May;37(5):1108–1114. [PMC free article] [PubMed]
  • Milhous WK, Gerena L, Kyle DE, Oduola AM. In vitro strategies for circumventing antimalarial drug resistance. Prog Clin Biol Res. 1989;313:61–72. [PubMed]
  • Molyneux ME, Taylor TE, Wirima JJ, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med. 1989 May;71(265):441–459. [PubMed]
  • Muhia DK, Thomas CG, Ward SA, Edwards G, Mberu EK, Watkins WM. Ferriprotoporphyrin catalysed decomposition of artemether: analytical and pharmacological implications. Biochem Pharmacol. 1994 Aug 30;48(5):889–895. [PubMed]
  • Pe Than Myint, Tin Shwe The efficacy of artemether (qinghaosu) in Plasmodium falciparum and P. vivax in Burma. Southeast Asian J Trop Med Public Health. 1986 Mar;17(1):19–22. [PubMed]
  • Pe Than Myint, Tin Shwe A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria. Trans R Soc Trop Med Hyg. 1987;81(4):559–561. [PubMed]
  • Pe Than Myint, Tin Shwe, Lin Soe, Ye Htut, Win Myint Clinical study of the treatment of cerebral malaria with artemether (qinghaosu derivative). Trans R Soc Trop Med Hyg. 1989 Jan-Feb;83(1):72–72. [PubMed]
  • Na Bangchang K, Karbwang J, Thomas CG, Thanavibul A, Sukontason K, Ward SA, Edwards G. Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute, uncomplicated falciparum malaria. Br J Clin Pharmacol. 1994 Mar;37(3):249–253. [PMC free article] [PubMed]
  • Navaratnam V, Mansor SM, Chin LK, Mordi MN, Asokan M, Nair NK. Determination of artemether and dihydroartemisinin in blood plasma by high-performance liquid chromatography for application in clinical pharmacological studies. J Chromatogr B Biomed Appl. 1995 Jul 21;669(2):289–294. [PubMed]
  • Nosten F, Luxemburger C, ter Kuile FO, Woodrow C, Eh JP, Chongsuphajaisiddhi T, White NJ. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J Infect Dis. 1994 Oct;170(4):971–977. [PubMed]
  • Ortiz de Montellano PR. Free radical modification of prosthetic heme groups. Pharmacol Ther. 1990;48(1):95–120. [PubMed]
  • Peters W, Li ZL, Robinson BL, Warhurst DC. The chemotherapy of rodent malaria, XL. The action of artemisinin and related sesquiterpenes. Ann Trop Med Parasitol. 1986 Oct;80(5):483–489. [PubMed]
  • Peters W, Robinson BL, Rossier JC, Jefford CW. The chemotherapy of rodent malaria. XLVIII. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 1: Studies leading to the development of novel cis-fused cyclopenteno derivatives. Ann Trop Med Parasitol. 1993 Feb;87(1):1–7. [PubMed]
  • Peters W, Robinson BL, Rossier JC, Misra D, Jefford CW, Rossiter JC. The chemotherapy of rodent malaria. XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 2: Structure-activity studies on cis-fused cyclopenteno-1,2,4-trioxanes (fenozans) against drug-sensitive and drug-resistant lines of Plasmodium berghei and P. yoelii ssp. NS in vivo. Ann Trop Med Parasitol. 1993 Feb;87(1):9–16. [PubMed]
  • Peters W, Robinson BL, Tovey G, Rossier JC, Jefford CW. The chemotherapy of rodent malaria. L. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 3: Observations on 'Fenozan-50F', a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane. Ann Trop Med Parasitol. 1993 Apr;87(2):111–123. [PubMed]
  • Phillips-Howard PA. Regulation of drug use and post-registration surveillance. Trans R Soc Trop Med Hyg. 1994 Jun;88 (Suppl 1):S59–S62. [PubMed]
  • Posner GH, McGarvey DJ, Oh CH, Kumar N, Meshnick SR, Asawamahasadka W. Structure-activity relationships of lactone ring-opened analogs of the antimalarial 1,2,4-trioxane artemisinin. J Med Chem. 1995 Feb 17;38(4):607–612. [PubMed]
  • Posner GH, Oh CH, Gerena L, Milhous WK. Extraordinarily potent antimalarial compounds: new, structurally simple, easily synthesized, tricyclic 1,2,4-trioxanes. J Med Chem. 1992 Jun 26;35(13):2459–2467. [PubMed]
  • Posner GH, Oh CH, Wang D, Gerena L, Milhous WK, Meshnick SR, Asawamahasadka W. Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity. J Med Chem. 1994 Apr 29;37(9):1256–1258. [PubMed]
  • Posner GH, Oh CH, Webster HK, Ager AL, Jr, Rossan RN. New, antimalarial, tricyclic 1,2,4-trioxanes: evaluations in mice and monkeys. Am J Trop Med Hyg. 1994 Apr;50(4):522–526. [PubMed]
  • Posner GH, Wang D, Cumming JN, Oh CH, French AN, Bodley AL, Shapiro TA. Further evidence supporting the importance of and the restrictions on a carbon-centered radical for high antimalarial activity of 1,2,4-trioxanes like artemisinin. J Med Chem. 1995 Jun 23;38(13):2273–2275. [PubMed]
  • Pu YM, Torok DS, Ziffer H, Pan XQ, Meshnick SR. Synthesis and antimalarial activities of several fluorinated artemisinin derivatives. J Med Chem. 1995 Sep 29;38(20):4120–4124. [PubMed]
  • Pu YM, Ziffer H. Synthesis and antimalarial activities of 12 beta-allyldeoxoartemisinin and its derivatives. J Med Chem. 1995 Feb 17;38(4):613–616. [PubMed]
  • Roth EF, Jr, Brotman DS, Vanderberg JP, Schulman S. Malarial pigment-dependent error in the estimation of hemoglobin content in Plasmodium falciparum-infected red cells: implications for metabolic and biochemical studies of the erythrocytic phases of malaria. Am J Trop Med Hyg. 1986 Sep;35(5):906–911. [PubMed]
  • Salako LA, Guiguemde R, Mittelholzer ML, Haller L, Sorenson F, Stürchler D. Ro 42-1611 in the treatment of patients with mild malaria: a clinical trial in Nigeria and Burkina Faso. Trop Med Parasitol. 1994 Sep;45(3):284–287. [PubMed]
  • Salako LA, Walker O, Sowunmi A. Parenteral therapy of moderately severe malaria: comparison of intramuscular artemether and intramuscular sulfadoxine-pyrimethamine. Trans R Soc Trop Med Hyg. 1994 Jan-Feb;88(1):89–91. [PubMed]
  • Sano M, Akyol CV, Tungtrongchitr A, Ito M, Ishih A. Studies on chemotherapy of parasitic helminths: efficacy of artemether on Japanese strain of Schistosoma japonicum in mice. Southeast Asian J Trop Med Public Health. 1993 Mar;24(1):53–56. [PubMed]
  • Scott MD, Meshnick SR, Williams RA, Chiu DT, Pan HC, Lubin BH, Kuypers FA. Qinghaosu-mediated oxidation in normal and abnormal erythrocytes. J Lab Clin Med. 1989 Oct;114(4):401–406. [PubMed]
  • Shukla KL, Gund TM, Meshnick SR. Molecular modeling studies of the artemisinin (qinghaosu)-hemin interaction: docking between the antimalarial agent and its putative receptor. J Mol Graph. 1995 Aug;13(4):215–222. [PubMed]
  • Tin Shwe, Pe Than Myint, Ye Htut, Win Myint, Lin Soe The effect of mefloquine-artemether compared with quinine on patients with complicated falciparum malaria. Trans R Soc Trop Med Hyg. 1988;82(5):665–666. [PubMed]
  • Shwe T, Myint PT, Myint W, Htut Y, Soe L, Thwe M. Clinical studies on treatment of cerebral malaria with artemether and mefloquine. Trans R Soc Trop Med Hyg. 1989 Jul-Aug;83(4):489–489. [PubMed]
  • Somo-Moyou R, Mittelholzer ML, Sorenson F, Haller L, Stürchler D. Efficacy of Ro 42-1611 (arteflene) in the treatment of patients with mild malaria: a clinical trial in Cameroon. Trop Med Parasitol. 1994 Sep;45(3):288–291. [PubMed]
  • Song ZY, Zhao KC. Studies of qinghaosu and its active derivatives in biological materials and their pharmacokinetics. Proc Chin Acad Med Sci Peking Union Med Coll. 1989;4(4):229–234. [PubMed]
  • Stahel E, Druilhe P, Gentilini M. Antagonism of chloroquine with other antimalarials. Trans R Soc Trop Med Hyg. 1988;82(2):221–221. [PubMed]
  • Nguyen DS, Dao BH, Nguyen PD, Nguyen VH, Le NB, Mai VS, Meshnick SR. Treatment of malaria in Vietnam with oral artemisinin. Am J Trop Med Hyg. 1993 Mar;48(3):398–402. [PubMed]
  • Tawfik AF, Bishop SJ, Ayalp A, el-Feraly FS. Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal mice. Int J Immunopharmacol. 1990;12(4):385–389. [PubMed]
  • Taylor TE, Wills BA, Kazembe P, Chisale M, Wirima JJ, Ratsma EY, Molyneux ME. Rapid coma resolution with artemether in Malawian children with cerebral malaria. Lancet. 1993 Mar 13;341(8846):661–662. [PubMed]
  • ter Kuile F, White NJ, Holloway P, Pasvol G, Krishna S. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp Parasitol. 1993 Feb;76(1):85–95. [PubMed]
  • Thomas CG, Ward SA, Edwards G. Selective determination, in plasma, of artemether and its major metabolite, dihydroartemisinin, by high-performance liquid chromatography with ultraviolet detection. J Chromatogr. 1992 Nov 27;583(1):131–136. [PubMed]
  • Titulaer HA, Zuidema J, Kager PA, Wetsteyn JC, Lugt CB, Merkus FW. The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers. J Pharm Pharmacol. 1990 Nov;42(11):810–813. [PubMed]
  • Torok DS, Ziffer H, Meshnick SR, Pan XQ, Ager A. Syntheses and antimalarial activities of N-substituted 11-azaartemisinins. J Med Chem. 1995 Dec 22;38(26):5045–5050. [PubMed]
  • Vennerstrom JL, Fu HN, Ellis WY, Ager AL, Jr, Wood JK, Andersen SL, Gerena L, Milhous WK. Dispiro-1,2,4,5-tetraoxanes: a new class of antimalarial peroxides. J Med Chem. 1992 Aug 7;35(16):3023–3027. [PubMed]
  • Venugopalan B, Bapat CP, Karnik PJ, Chatterjee DK, Iyer N, Lepcha D. Antimalarial activity of novel ring-contracted artemisinin derivatives. J Med Chem. 1995 May 26;38(11):1922–1927. [PubMed]
  • Walker O, Salako LA, Omokhodion SI, Sowunmi A. An open randomized comparative study of intramuscular artemether and intravenous quinine in cerebral malaria in children. Trans R Soc Trop Med Hyg. 1993 Sep-Oct;87(5):564–566. [PubMed]
  • Wang TY, Xu RC. Clinical studies of treatment of falciparum malaria with artemether, a derivative of qinghaosu. J Tradit Chin Med. 1985 Dec;5(4):240–242. [PubMed]
  • Wanwimolruk S, Edwards G, Ward SA, Breckenridge AM. The binding of the antimalarial arteether to human plasma proteins in-vitro. J Pharm Pharmacol. 1992 Nov;44(11):940–942. [PubMed]
  • Weatherall DJ. Common genetic disorders of the red cell and the 'malaria hypothesis'. Ann Trop Med Parasitol. 1987 Oct;81(5):539–548. [PubMed]
  • Webster HK, Lehnert EK. Chemistry of artemisinin: an overview. Trans R Soc Trop Med Hyg. 1994 Jun;88 (Suppl 1):S27–S29. [PubMed]
  • Wei N, Sadrzadeh SM. Enhancement of hemin-induced membrane damage by artemisinin. Biochem Pharmacol. 1994 Aug 17;48(4):737–741. [PubMed]
  • Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta Trop. 1994 Mar;56(2-3):143–156. [PubMed]
  • Wernsdorfer WH, Payne D. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol Ther. 1991;50(1):95–121. [PubMed]
  • Wesche DL, DeCoster MA, Tortella FC, Brewer TG. Neurotoxicity of artemisinin analogs in vitro. Antimicrob Agents Chemother. 1994 Aug;38(8):1813–1819. [PMC free article] [PubMed]
  • White NJ. Artemisinin: current status. Trans R Soc Trop Med Hyg. 1994 Jun;88 (Suppl 1):S3–S4. [PubMed]
  • White NJ, Waller D, Crawley J, Nosten F, Chapman D, Brewster D, Greenwood BM. Comparison of artemether and chloroquine for severe malaria in Gambian children. Lancet. 1992 Feb 8;339(8789):317–321. [PubMed]
  • Win K, Than M, Thwe Y. Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria. Bull World Health Organ. 1992;70(6):777–782. [PMC free article] [PubMed]
  • Woerdenbag HJ, Moskal TA, Pras N, Malingré TM, el-Feraly FS, Kampinga HH, Konings AW. Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. J Nat Prod. 1993 Jun;56(6):849–856. [PubMed]
  • Woerdenbag HJ, Pras N, van Uden W, Wallaart TE, Beekman AC, Lugt CB. Progress in the research of artemisinin-related antimalarials: an update. Pharm World Sci. 1994 Aug 5;16(4):169–180. [PubMed]
  • Xiao SH, Catto BA. In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob Agents Chemother. 1989 Sep;33(9):1557–1562. [PMC free article] [PubMed]
  • Yang DM, Liew FY. Effects of qinghaosu (artemisinin) and its derivatives on experimental cutaneous leishmaniasis. Parasitology. 1993 Jan;106(Pt 1):7–11. [PubMed]
  • Ke OY, Krug EC, Marr JJ, Berens RL. Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives. Antimicrob Agents Chemother. 1990 Oct;34(10):1961–1965. [PMC free article] [PubMed]
  • Yang YZ, Asawamahasakda W, Meshnick SR. Alkylation of human albumin by the antimalarial artemisinin. Biochem Pharmacol. 1993 Jul 20;46(2):336–339. [PubMed]
  • Yang YZ, Little B, Meshnick SR. Alkylation of proteins by artemisinin. Effects of heme, pH, and drug structure. Biochem Pharmacol. 1994 Aug 3;48(3):569–573. [PubMed]
  • Yuthavong Y, Butthep P, Bunyaratvej A, Fucharoen S. Decreased sensitivity of artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and/or hemoglobin constant spring erythrocytes. J Clin Invest. 1989 Feb;83(2):502–505. [PMC free article] [PubMed]
  • Yuthavong Y, Bunyaratvej A, Kamchonwongpaisan S. Increased susceptibility of malaria-infected variant erythrocytes to the mononuclear phagocyte system. Blood Cells. 1990;16(2-3):591–597. [PubMed]
  • Yuthavong Y, Wilairat P. Protection against malaria by thalassaemia and haemoglobin variants. Parasitol Today. 1993 Jul;9(7):241–245. [PubMed]
  • Zhang F, Gosser DK, Jr, Meshnick SR. Hemin-catalyzed decomposition of artemisinin (qinghaosu). Biochem Pharmacol. 1992 Apr 15;43(8):1805–1809. [PubMed]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...